Abstract
A novel cell line derived from a human glioblastoma (GB), named GB-val4, has been established and characterized. GB-val4 cells were hyperdiploid, with many numerical and structural chromosomal rearrangements. The cell line did not show mutations in IDH1/IDH2 genes or EGFR amplification, but it presented two missense mutations in TP53, which imply a very low p53 protein activity within the cell line. Cells also had gain of TP73 copies, hypermethylation of APC, CASP8 and RASSF1, increased expression of ARF1, CDH1 and NF-κB and decreased expression of CDKN2A. Tumorigenity was demonstrated by transplant of GB-val4 cells into athymic nude mice, where solid tumors were grown. Interestingly, a high percentage of GB-val4 cells presented expression of GSC markers CD133 or CD44. These GSC markers were increased in neurosphere cultures, which better mimic solid tumor conditions and maintain the genetic features of the tumor cells. In this study, we aimed to define the characteristics of this novel cell line and its applications in human cancer research. With its genetic features and a poor p53 activity, GB-val4 cells resemble GB tumors. Moreover, the important presence of GSCs in adherent cultures and especially in neurosphere cultures ma...Continue Reading
References
Jan 1, 1995·Human Pathology·M S ShurbajiT S Thurmond
Jun 17, 2003·Laboratory Investigation; a Journal of Technical Methods and Pathology·Rosario Gil-BensoAntonio Llombart-Bosch
Jun 28, 2005·Journal of Neuropathology and Experimental Neurology·Hiroko Ohgaki, Paul Kleihues
May 16, 2006·Cancer Cell·Jeongwu LeeHoward A Fine
Nov 3, 2006·Cancer Research·Serena PellegattaGaetano Finocchiaro
Jul 16, 2009·Genes, Chromosomes & Cancer·Hanne-Sofie S DahlbackSverre Heim
Jan 7, 2010·Neuropathology : Official Journal of the Japanese Society of Neuropathology·Rafael BenitoConcha Lopez-Gines
Feb 26, 2010·Cold Spring Harbor Perspectives in Biology·Magali OlivierPierre Hainaut
Oct 15, 2010·Integrative Biology : Quantitative Biosciences From Nano to Macro·Tianhai TianAngus Harding
Jan 20, 2012·Nature·Mel Greaves, Carlo C Maley
Mar 31, 2012·Nature·Jordi BarretinaLevi A Garraway
Aug 6, 2013·Genes, Chromosomes & Cancer·Beatriz SoldevillaGemma Domínguez
Oct 18, 2013·Nature·Cyriac KandothLi Ding
Oct 25, 2013·Current Opinion in Neurology·Kenneth YanJeremy N Rich
Jan 23, 2014·Molecular BioSystems·Prudence DonovanAngus Harding
Mar 22, 2014·Cancer Cell·Patricia A J Muller, Karen H Vousden
Sep 19, 2014·Science Translational Medicine·Suzanne CarreiraGerhardt Attard
Dec 17, 2014·Carcinogenesis·Melanie JacksonAnna Nowak
Mar 31, 2015·Cancers·Meena Jhanwar-UniyalRaj Murali
Apr 15, 2015·Neuroscience·L NavarroM J Cerdá-Nicolás
Mar 31, 2016·PloS One·Zev A BinderGary L Gallia
May 10, 2016·Acta Neuropathologica·David N LouisDavid W Ellison
Jun 23, 2016·Human Mutation·Liacine BouaounMagali Olivier
Jul 6, 2017·Cytotechnology·Rosario Gil-BensoMiguel Cerdá-Nicolás
May 12, 2019·Investigational New Drugs·Javier MegíasMiguel Cerdá-Nicolás